Proposed LCDs

When there are Proposed Local Coverage Determinations (LCDs) that are in the comment period, this webpage will provide a summary of comments received and Noridian's response. This information will remain on this webpage for at least six months.

Status Indicators

D = Proposed under development, not yet released for comment
C = Proposed LCD released for comment
E = Formal comment period has ended; comments now being considered
F = Final new/revised LCD has been issued for notice
A = Active policy: notice period complete and the policy is in effect

Send Proposed LCD Comments to:

Mail:
Noridian Medicare JF Part B
Attention: Proposed LCD Comments
PO Box 6781
Fargo, ND 58108-6781
Email: policydraft@noridian.com

X
 
Proposed LCD and LCA Title Release Date of Proposed LCD for Comment End Date for Comment Period Current Status Comments / Responses Date of Release for Notice Link to Final LCD
Colon Capsule Endoscopy (CCE)

Billing and Coding: Colon Capsule Endoscopy (CCE)
08/05/21 09/18/21 F View 11/04/21 View
Epidural Steroid Injections for Pain Management

Billing and Coding: Epidural Steroid Injections for Pain Management
02/10/22 03/26/22 F View 05/05/22 View
Lumbar Epidural Injections

Billing and Coding: Lumbar Epidural Injections
05/05/22 06/11/22 C      
Micro-Invasive Glaucoma Surgery (MIGS)

Billing and Coding: Micro-Invasive Glaucoma Surgery (MIGS)
05/20/21 07/06/21 F View 08/19/21 View
MolDX: 4Kscore® Assay 4/28/22 6/11/22 C      
MolDX: Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer

Billing and Coding: MolDx: Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
05/20/21 07/03/21 E      
MolDX: Melanoma Risk Stratification Molecular Testing

Billing and Coding: MolDx: Melanoma Risk Stratification Molecular Testing
05/20/21 07/03/21 E      
MolDX: Minimal Residual Disease Testing for Cancer

Billing and Coding: MolDX: Minimal Residual Disease Testing for Cancer
10/08/20 11/22/20 A View 11/18/21 View
MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing

Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
05/20/21 07/03/21 F View 03/03/22 View
MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia

Billing and Coding: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia
4/28/22 6/11//2022 C      
MolDX: Next-Generation Sequencing Lab-Developed Tests for Inherited Cancer Syndromes

Billing and Coding: MolDx Next-Generation Sequencing Lab-Developed Tests for Inherited Cancer Syndromes
05/20/21 07/31/21 E      
MolDX: Plasma-Based Genomic Profiling in Solid Tumors

Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors
01/20/22 03/05/22 E      
Nerve Blockade for Treatment of Chronic Pain and Neuropathy

Billing and Coding: Nerve Blockade for Treatment of Chronic Pain and Neuropathy
4/28/2022 06/11/22 C      
Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease

Billing and Coding: Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
01/20/22 03/05/22 E      
Platelet Rich Plasma Injections for Non-Wound Injections

Billing and Coding: Platelet Rich Plasma Injections for Non-Wound Injections
06/24/21 08/04/21 F View 12/09/21 View

 

When a "Draft" LCD becomes "Final/Future," go to the Future LCDs page to view a specific future LCD.

  • View All Future LCDs by state. Within the table, each state selection will redirect you to the MCD on the CMS website. Note: All LCDs for JE states are the same.

 

Last Updated Tue, 17 May 2022 13:43:09 +0000